Academia + Industry with BridgeBio's Dr. Michael Henderson

We love to hear from our listeners. Send us a message. BridgeBio has a whopping 18+ pre-clinical to clinical-stage candidates in its pipeline representing an impressive array of modalities and targets. It boasts a couple of commercial wins under its belt. The company is no stranger to developing business strategies for success. Central to that success are partnerships with scientists and researchers to fuel pipeline expansion. On this episode of The Business of Biotech, BridgeBio Chief ...